B-type natriuretic peptide measurement in primary care; magnitude of associations with cardiovascular risk factors and their therapies. Observations from the STOP-HF (St. Vincent's Screening TO Prevent Heart Failure) study.
Authors
Conlon, Carmel MDawkins, Ian
O'Loughlin, Christina
Gibson, Denise
Kelleher, Cecily C
Ledwidge, Mark
McDonald, Kenneth
Affiliation
Department of Cardiology, St. Vincent's University Hospital, Dublin, Ireland.Issue Date
2012-02-01T10:31:10ZMeSH
AdultAged
Blood Chemical Analysis/*methods/standards
Female
Heart Failure/*blood/diagnosis/prevention & control/therapy
Humans
Male
Middle Aged
Multivariate Analysis
Natriuretic Peptide, Brain/*blood
*Primary Health Care
Reference Values
Risk Factors
Metadata
Show full item recordCitation
Clin Chem Lab Med. 2011 Apr;49(4):719-28. Epub 2011 Jan 31.Journal
Clinical chemistry and laboratory medicine : CCLM / FESCCDOI
10.1515/CCLM.2011.098PubMed ID
21275814Abstract
BACKGROUND: An effective prevention strategy for heart failure in primary care requires a reliable screening tool for asymptomatic ventricular dysfunction. Preliminary data indicate that B-type natriuretic peptide (BNP) may be suitable for this task. However, for the most effective use of this peptide, the interrelationships between associated risk factors and their therapies on BNP, and in particular their magnitude of effect, needs to be established in a large primary care population. Therefore, the objective of the study was to establish the extent of the association between BNP, cardiovascular risk factors and their therapies. METHODS: BNP measurement and clinical review was preformed on 1122 primary care patients with cardiovascular risk factors. Multivariate analyses identified significant associates of BNP concentrations which were further explored to establish the magnitude of their association. RESULTS: Associates of BNP were age (1.36-fold increase in BNP/decade), female (1.28), beta-blockers (1.90), myocardial infarction (1.36), arrhythmia (1.98), diastolic blood pressure; all p<0.01. A novel method was devised that plotted median BNP per sliding decade of age for the various combinations of these principal associates. CONCLUSIONS: The data presented underline the importance of considering several clinical and therapeutic factors when interpreting BNP concentrations. Most of these variables were associated with increased concentrations, which may in part explain the observed false-positive rates for detecting ventricular dysfunction using this peptide. Furthermore, the design of studies or protocols using BNP as an endpoint or a clinical tool should take particular account of these associations. This analysis provides the foundation for age, risk factor and therapy adjusted reference ranges for BNP in this setting.Language
engISSN
1434-6621 (Print)1434-6621 (Linking)
ae974a485f413a2113503eed53cd6c53
10.1515/CCLM.2011.098
Scopus Count
Collections
Related articles
- Natriuretic peptide-based screening and collaborative care for heart failure: the STOP-HF randomized trial.
- Authors: Ledwidge M, Gallagher J, Conlon C, Tallon E, O'Connell E, Dawkins I, Watson C, O'Hanlon R, Bermingham M, Patle A, Badabhagni MR, Murtagh G, Voon V, Tilson L, Barry M, McDonald L, Maurer B, McDonald K
- Issue date: 2013 Jul 3
- Cost-effectiveness of natriuretic peptide-based screening and collaborative care: a report from the STOP-HF (St Vincent's Screening TO Prevent Heart Failure) study.
- Authors: Ledwidge MT, O'Connell E, Gallagher J, Tilson L, James S, Voon V, Bermingham M, Tallon E, Watson C, O'Hanlon R, Barry M, McDonald K
- Issue date: 2015 Jul
- [Screening for asymptomatic left ventricular systolic dysfunction in high-risk patients. Preliminary experience with a program based on the use of ECG and natriuretic peptide].
- Authors: Tarantini L, Cioffi G, Di Lenarda A, Valle R, Pulignano G, Del Sindaco D, Frigo G, Soravia G, Tessier R, Catania G
- Issue date: 2008 Dec
- Age- and gender-specific brain natriuretic peptide (BNP) reference ranges in primary care.
- Authors: Keyzer JM, Hoffmann JJ, Ringoir L, Nabbe KC, Widdershoven JW, Pop VJ
- Issue date: 2014 Sep
- Comparable increase of B-type natriuretic peptide and amino-terminal pro-B-type natriuretic peptide levels in patients with severe sepsis, septic shock, and acute heart failure.
- Authors: Rudiger A, Gasser S, Fischler M, Hornemann T, von Eckardstein A, Maggiorini M
- Issue date: 2006 Aug